Evolus, Inc. (LON:0K16)
London flag London · Delayed Price · Currency is GBP · Price in USD
14.58
+0.43 (3.00%)
At close: Jan 31, 2025

Evolus Statistics

Total Valuation

Evolus has a market cap or net worth of GBP 203.66 million. The enterprise value is 285.42 million.

Market Cap203.66M
Enterprise Value 285.42M

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date Mar 6, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 63.32M
Shares Outstanding n/a
Shares Change (YoY) +5.96%
Shares Change (QoQ) +0.29%
Owned by Insiders (%) 9.91%
Owned by Institutions (%) 69.13%
Float 46.40M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.96
PB Ratio -9.52
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -6.55
EV / Sales 1.36
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -7.28

Financial Position

The company has a current ratio of 2.02

Current Ratio 2.02
Quick Ratio 1.41
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -2.94
Interest Coverage -1.88

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -10.60%
Return on Invested Capital (ROIC) -18.16%
Return on Capital Employed (ROCE) -24.99%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 646,307
Profits Per Employee -132,421
Employee Count329
Asset Turnover 1.27
Inventory Turnover 3.99

Taxes

In the past 12 months, Evolus has paid 544,564 in taxes.

Income Tax 544,564
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +13.00% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +13.00%
50-Day Moving Average 12.29
200-Day Moving Average 13.53
Relative Strength Index (RSI) 65.90
Average Volume (20 Days) 3,893

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 6.13

Income Statement

In the last 12 months, Evolus had revenue of GBP 212.64 million and -43.57 million in losses. Loss per share was -0.68.

Revenue212.64M
Gross Profit 141.68M
Operating Income -28.31M
Pretax Income -43.02M
Net Income -43.57M
EBITDA -23.38M
EBIT -28.31M
Loss Per Share -0.68
Full Income Statement

Balance Sheet

The company has 32.38 million in cash and 115.23 million in debt, with a net cash position of -82.85 million.

Cash & Cash Equivalents 32.38M
Total Debt 115.23M
Net Cash -82.85M
Net Cash Per Share n/a
Equity (Book Value) -21.40M
Book Value Per Share -0.33
Working Capital 50.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.41 million and capital expenditures -1.79 million, giving a free cash flow of -39.19 million.

Operating Cash Flow -37.41M
Capital Expenditures -1.79M
Free Cash Flow -39.19M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 66.63%, with operating and profit margins of -13.32% and -20.49%.

Gross Margin 66.63%
Operating Margin -13.32%
Pretax Margin -20.23%
Profit Margin -20.49%
EBITDA Margin -11.00%
EBIT Margin -13.32%
FCF Margin n/a

Dividends & Yields

Evolus does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.96%
Shareholder Yield -5.96%
Earnings Yield -21.39%
FCF Yield -19.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Evolus has an Altman Z-Score of -1.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.38
Piotroski F-Score 2